These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30404295)

  • 1. High-Throughput Assessment of Drug Cardiac Safety Using a High-Speed Impedance Detection Technology-Based Heart-on-a-Chip.
    Zhang X; Wang T; Wang P; Hu N
    Micromachines (Basel); 2016 Jul; 7(7):. PubMed ID: 30404295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bridging Functional and Structural Cardiotoxicity Assays Using Human Embryonic Stem Cell-Derived Cardiomyocytes for a More Comprehensive Risk Assessment.
    Clements M; Millar V; Williams AS; Kalinka S
    Toxicol Sci; 2015 Nov; 148(1):241-60. PubMed ID: 26259608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An impedance-based approach using human iPSC-derived cardiomyocytes significantly improves in vitro prediction of in vivo cardiotox liabilities.
    Koci B; Luerman G; Duenbostell A; Kettenhofen R; Bohlen H; Coyle L; Knight B; Ku W; Volberg W; Woska JR; Brown MP
    Toxicol Appl Pharmacol; 2017 Aug; 329():121-127. PubMed ID: 28546047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cardiomyocyte-based biosensor for antiarrhythmic drug evaluation by simultaneously monitoring cell growth and beating.
    Wang T; Hu N; Cao J; Wu J; Su K; Wang P
    Biosens Bioelectron; 2013 Nov; 49():9-13. PubMed ID: 23708811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening, verification, and analysis of biomarkers for drug-induced cardiac toxicity in vitro based on RTCA coupled with PCR Array technology.
    Zhang L; Xu MX; Yin QS; Zhu CY; Cheng XL; Ren YR; Zhuang PW; Zhang YJ
    Toxicol Lett; 2017 Feb; 268():17-25. PubMed ID: 28099878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cellular impedance measures of cardiomyocyte cultures for drug screening applications.
    Peters MF; Scott CW; Ochalski R; Dragan YP
    Assay Drug Dev Technol; 2012 Dec; 10(6):525-32. PubMed ID: 22574652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human stem cell-derived cardiomyocytes in cellular impedance assays: bringing cardiotoxicity screening to the front line.
    Peters MF; Lamore SD; Guo L; Scott CW; Kolaja KL
    Cardiovasc Toxicol; 2015 Apr; 15(2):127-39. PubMed ID: 25134468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Effects of Electric Stimulation and Microgrooves in Cardiac Tissue-on-a-Chip for Drug Screening.
    Ren L; Zhou X; Nasiri R; Fang J; Jiang X; Wang C; Qu M; Ling H; Chen Y; Xue Y; Hartel MC; Tebon P; Zhang S; Kim HJ; Yuan X; Shamloo A; Dokmeci MR; Li S; Khademhosseini A; Ahadian S; Sun W
    Small Methods; 2020 Oct; 4(10):. PubMed ID: 34423115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Heart Cardiomyocytes in Drug Discovery and Research: New Opportunities in Translational Sciences.
    Abi-Gerges N; Miller PE; Ghetti A
    Curr Pharm Biotechnol; 2020; 21(9):787-806. PubMed ID: 31820682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing Drug-Induced Mitochondrial Toxicity in Cardiomyocytes: Implications for Preclinical Cardiac Safety Evaluation.
    Tang X; Wang Z; Hu S; Zhou B
    Pharmaceutics; 2022 Jun; 14(7):. PubMed ID: 35890211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional cardiotoxicity profiling and screening using the xCELLigence RTCA Cardio System.
    Xi B; Wang T; Li N; Ouyang W; Zhang W; Wu J; Xu X; Wang X; Abassi YA
    J Lab Autom; 2011 Dec; 16(6):415-21. PubMed ID: 22093298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicity.
    Yang X; Papoian T
    J Appl Toxicol; 2018 Sep; 38(9):1166-1176. PubMed ID: 29484688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes.
    Guo L; Abrams RM; Babiarz JE; Cohen JD; Kameoka S; Sanders MJ; Chiao E; Kolaja KL
    Toxicol Sci; 2011 Sep; 123(1):281-9. PubMed ID: 21693436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular impedance assays for predictive preclinical drug screening of kinase inhibitor cardiovascular toxicity.
    Lamore SD; Kamendi HW; Scott CW; Dragan YP; Peters MF
    Toxicol Sci; 2013 Oct; 135(2):402-13. PubMed ID: 23897988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro model for assessing arrhythmogenic properties of drugs based on high-resolution impedance measurements.
    Nguemo F; Šarić T; Pfannkuche K; Watzele M; Reppel M; Hescheler J
    Cell Physiol Biochem; 2012; 29(5-6):819-32. PubMed ID: 22613982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and functional screening in human induced-pluripotent stem cell-derived cardiomyocytes accurately identifies cardiotoxicity of multiple drug types.
    Doherty KR; Talbert DR; Trusk PB; Moran DM; Shell SA; Bacus S
    Toxicol Appl Pharmacol; 2015 May; 285(1):51-60. PubMed ID: 25841593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Universal and Sensitive Drug Assessment Biosensing Platform Using Optimal Mechanical Beating Detection of Single Cardiomyocyte.
    Xu D; Xiao H; Wang S; Li H; Chen HJ; Liu C; Hu N
    ACS Nano; 2022 Sep; 16(9):15484-15494. PubMed ID: 36094397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance beating pattern function of human induced pluripotent stem cell-derived cardiomyocyte-based biosensors for hERG inhibition recognition.
    Hu N; Wang T; Wang Q; Zhou J; Zou L; Su K; Wu J; Wang P
    Biosens Bioelectron; 2015 May; 67():146-53. PubMed ID: 25153933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced functional cardiotoxicity screening in stem cell-derived human and mouse cardiomyocytes: effects of reference compounds.
    Himmel HM
    J Pharmacol Toxicol Methods; 2013; 68(1):97-111. PubMed ID: 23702537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Next-Generation Biosensing Platform for Simultaneous Detection of Mechano- and Electrophysiology of the Drug-Induced Cardiomyocytes.
    Oyunbaatar NE; Dai Y; Shanmugasundaram A; Lee BK; Kim ES; Lee DW
    ACS Sens; 2019 Oct; 4(10):2623-2630. PubMed ID: 31535848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.